Alok Goel

1.8k total citations
55 papers, 1.3k citations indexed

About

Alok Goel is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Organic Chemistry. According to data from OpenAlex, Alok Goel has authored 55 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Oncology, 16 papers in Pulmonary and Respiratory Medicine and 10 papers in Organic Chemistry. Recurrent topics in Alok Goel's work include Ferrocene Chemistry and Applications (9 papers), Electrochemical Analysis and Applications (7 papers) and Lung Cancer Treatments and Mutations (7 papers). Alok Goel is often cited by papers focused on Ferrocene Chemistry and Applications (9 papers), Electrochemical Analysis and Applications (7 papers) and Lung Cancer Treatments and Mutations (7 papers). Alok Goel collaborates with scholars based in India, Switzerland and Ireland. Alok Goel's co-authors include Matthew A. Brown, Zareen Abbas, Armin Kleibert, Peter T.M. Kenny, Richard G. Green, Todd M. Squires, Sylvio May, John F. Gallagher, Giorgia Olivieri and Kumar Prabhash and has published in prestigious journals such as Angewandte Chemie International Edition, The Journal of Chemical Physics and Journal of Clinical Oncology.

In The Last Decade

Alok Goel

52 papers receiving 1.3k citations

Peers

Countries citing papers authored by Alok Goel

Since Specialization

Citations

This map shows the geographic impact of Alok Goel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alok Goel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alok Goel more than expected).

Fields of papers citing papers by Alok Goel

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alok Goel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alok Goel. The network helps show where Alok Goel may publish in the future.

Co-authorship network of co-authors of Alok Goel

This figure shows the co-authorship network connecting the top 25 collaborators of Alok Goel. A scholar is included among the top collaborators of Alok Goel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alok Goel. Alok Goel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Outcome of early detection approach in control of breast, cervical, and oral cancer: Experience from a rural cancer center in India 2024 ·International Journal of Cancer ·Atul Budukh, Tapas Dora, (unknown), (unknown), Alok Goel, (unknown), Amandeep Kaur, (unknown), (unknown), (unknown), Pankaj Chaturvedi, Rajendra Badwe	2
2	A Clinicopathological Analysis of Molecular Subtypes of Breast Cancer using Immunohistochemical Surrogates: A 6-Year Institutional Experience from a Tertiary Cancer Center in North India 2023 ·SHILAP Revista de lepidopterología ·(unknown), (unknown), Aishwarya Sharma, (unknown), Debashish Chaudhary, Alok Goel, Tapas Dora, (unknown), (unknown), Jigeeshu Vasishtha Divatia	2
3	Question-Type Identification for Academic Questions in Online Learning Platform 2023 ·(unknown), Alok Goel, (unknown), (unknown)	2
4	Nonlinear Optical Properties of Discotic Hexylthiotruxene Derivatives 2023 ·ACS Omega ·Manish Kumar, Sreekanth Perumbilavil, (unknown), Alok Goel, Reji Philip, Sandeep Kumar	4
5	Neoadjuvant chemoradiotherapy followed by surgery for operable carcinoma esophagus: Ground reality in a tertiary care center of rural India - A retrospective audit 2021 ·Cancer Research Statistics and Treatment ·(unknown), (unknown), Abhishek Chatterjee, (unknown), Alok Goel, (unknown), Debashish Chaudhary, Rakesh Kumar Sharma, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Jaiprakash Agarwal, Shyam Kishore Shrivastava, Rakesh Kapoor	6
6	Presentation and Spectrum of Male Breast Cancer in a Rural Cancer Center in a Subunit of Tata Memorial Center, India 2021 ·Indian Journal of Surgical Oncology ·(unknown), (unknown), Rakesh K. Sharma, (unknown), Debashish Chaudhary, Alok Goel, Tapas Dora, (unknown), Rakesh Kapoor	2
7	Lenvatinib: A narrative drug review 2021 ·Cancer Research Statistics and Treatment ·Alok Goel, (unknown)	9
8	Outcomes with second-line chemotherapy in advanced pancreatic cancers: A retrospective study from a tertiary cancer center in India 2018 ·Indian Journal of Cancer ·Vikas Ostwal, Anant Ramaswamy, (unknown), (unknown), (unknown), Alok Goel, Prabhat Bhargava, Sujay Srinivas, Suyash Kulkarni	2
9	Outcomes of gemcitabine-docetaxel as second-line chemotherapy in patients of advanced soft tissue sarcoma: A retrospective analysis 2018 ·Annals of Oncology ·(unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Alok Goel, Jyoti Bajpai	0
10	Treatment practices for metastatic pancreatic cancer: Can we deliver an appropriately efficacious and safe regimen in Indian patients? 2018 ·Indian Journal of Cancer ·Vikas Ostwal, Anant Ramaswamy, Alok Goel, Prabhat Bhargava, Sujay Srinivas, (unknown), Shailesh V. Shrikhande	6
11	Phase III study of gefitinib or pemetrexed with carboplatin in EGFR-mutated advanced lung adenocarcinoma 2017 ·ESMO Open ·Vijay Patil, Vanita Noronha, Amit Joshi, Anuradha Choughule, Atanu Bhattacharjee, Rajiv Kumar, Supriya Goud, Sucheta More, Anant Ramaswamy, (unknown), Nikhil Pande, (unknown), Alok Goel, Vikas Talreja, Abhishek Mahajan, Amit Janu, Nilendu Purandare, Kumar Prabhash	56
12	Efficacy of gefitinib in epidermal growth factor receptor-activating mutation-positive nonsmall cell lung cancer: Does exon 19 deletion differ from exon 21 mutation? 2017 ·Lung India ·Kumar Prabhash, (unknown), Vijay Patil, (unknown), Anuradha Chougule, Atanu Bhattacharjee, Rajiv Kumar, Supriya Goud, Sucheta More, (unknown), (unknown), (unknown), (unknown), Alok Goel, Vikas Talreja, Abhishek Mahajan, Amit Janu, Nilendu Purandare	2
13	P3.02b-094 Rebiopsy Post Progression in EGFR Mutated Lung Cancer 2017 ·Journal of Thoracic Oncology ·(unknown), Vijay Patil, (unknown), Amit Joshi, (unknown), (unknown), Abhishek Mahajan, Amit Janu, Supriya Goud, Sucheta More, (unknown), Anant Ramaswamy, Nikhil Pande, Alok Goel, Vikas Talreja, Kumar Prabhash	3
14	P3.02b-055 Impact of Pemetrexed Chemotherapy in Exon 19 or Exon 21 Mutated NSCLC 2017 ·Journal of Thoracic Oncology ·Vikas Talreja, Vanita Noronha, Vijay Patil, Amit Joshi, Anuradha Chougule, Abhishek Mahajan, Amit Janu, Supriya Goud, Sucheta More, (unknown), Anant Ramaswamy, Nikhil Pande, (unknown), Alok Goel, Kumar Prabhash	1
15	Impact of exon 19 versus exon 21 EGFR-activating mutation on outcomes with upfront pemetrexed–carboplatin chemotherapy 2017 ·ecancermedicalscience ·Vanita Noronha, Vijay Patil, Amit Joshi, Anuradha Chougule, Atanu Bhattacharjee, Rajiv Kumar, Sucheta More, Supriya Goud, (unknown), Anant Ramaswamy, Nikhil Pande, (unknown), Alok Goel, Vikas Talreja, Abhishek Mahajan, Amit Janu, Nilendu Purandare, Kumar Prabhash	2
16	Esterification of pseudoephedrine hydrochloride by citric acid in a solid dose pharmaceutical preparation 2016 ·Journal of Pharmaceutical and Biomedical Analysis ·Alok Goel, Zhicheng Zhao, Dan Sørensen, (unknown), Zhang Fa	5
17	Efficacy and safety of sorafenib in advanced renal cell cancer and validation of Heng criteria 2016 ·Indian Journal of Cancer ·(unknown), Amit D. Joshi, Anant Ramaswamy, (unknown), (unknown), Arun Chandrasekharan, Alok Goel, (unknown), Nilesh Sable, Archi Agrawal, Santosh Menon	5
18	Effect of X-ray spot size on liquid jet photoelectron spectroscopy 2015 ·Journal of Synchrotron Radiation ·Giorgia Olivieri, Alok Goel, Armin Kleibert, Matthew A. Brown	15
19	Micromultileaf collimator-based stereotactic radiosurgery for selected arteriovenous malformations: Technique and preliminary experience 2009 ·Journal of Cancer Research and Therapeutics ·Rakesh Jalali, Debnarayan Dutta, (unknown), Anusheel Munshi, Uday Limaye, Alok Goel, D. Deshpande, Rajiv Sarin	5
20	Electrochemical recognition of anions by 1,1′-N,N′-ferrocenoylbisamino acid esters 2006 ·Biosensors and Bioelectronics ·Alok Goel, Noel A. Brennan, (unknown), Peter T.M. Kenny	26

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact